Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950170-25-014245
Filing Date
2025-02-05
Accepted
2025-02-05 11:41:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 12334
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 28424
3 EX-99.2 ck0001669811-ex99_2.pdf EX-99.2 84033
  Complete submission text file 0000950170-25-014245.txt   169293
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Subject) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-85653 | Film No.: 25591772
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)

Mailing Address 2001 SHAWNEE MISSION PARKWAY SHAWNEE MISSION KS 66205
Business Address 2001 SHAWNEE MISSION PARKWAY SHAWNEE MISSION KS 66205 913-951-2700
Whetstone Capital Advisors, LLC (Filed by) CIK: 0001607278 (see all company filings)

EIN.: 273522666 | State of Incorp.: KS | Fiscal Year End: 1213
Type: SCHEDULE 13D